Agrobacterium tumefaciens‐mediated nuclear transformation of a biotechnologically important microalga—euglena gracilis

Abstract

Euglena gracilis (E. gracilis) is an attractive organism due to its evolutionary history and substantial potential to produce biochemicals of commercial importance. This study describes the establishment of an optimized protocol for the genetic transformation of E. gracilis mediated by Ag-robacterium (A. tumefaciens). E. gracilis was found to be highly sensitive to hygromycin and zeocin, thus offering a set of resistance marker genes for the selection of transformants. A. tumefaciens‐me-diated transformation (ATMT) yielded hygromycin‐resistant cells. However, hygromycin‐resistant cells hosting the gus gene (encoding β‐glucuronidase (GUS)) were found to be GUS‐negative, indi-cating that the gus gene had explicitly been silenced. To circumvent transgene silencing, GUS was expressed from the nuclear genome as transcriptional fusions with the hygromycin resistance gene (hptII) (encoding hygromycin phosphotransferase II) with the foot and mouth disease virus (FMDV)‐derived 2A self‐cleaving sequence placed between the coding sequences. ATMT of Euglena with the hptII‐2A–gus gene yielded hygromycin‐resistant, GUS‐positive cells. The transformation was verified by PCR amplification of the T‐DNA region genes, determination of GUS activity, and indirect immunofluorescence assays. Cocultivation factors optimization revealed that a higher number of transformants was obtained when A. tumefaciens LBA4404 (A600 = 1.0) and E. gracilis (A750 = 2.0) cultures were cocultured for 48 h at 19 °C in an organic medium (pH 6.5) containing 50 μM acetosyringone. Transformation efficiency of 8.26 ± 4.9% was achieved under the optimized cocul-tivation parameters. The molecular toolkits and method presented here can be used to bioengineer E. gracilis for producing high‐value products and fundamental studies.